Central Nervous System Prophylaxis With High-Dose Methotrexate Does Not Give Rise to Significant Electroencephalographic Changes in Children With Acute Lymphoblastic Leukemia

Lymphoblastic Leukemia ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate

Leukemia & Lymphoma ◽

10.1080/10428194.2018.1434879 ◽

2018 ◽

Vol 59 (10) ◽

pp. 2342-2351 ◽

Cited By ~ 6

Author(s):

Olga Zając-Spychała ◽

Mikolaj Pawlak ◽

Katarzyna Karmelita-Katulska ◽

Jakub Pilarczyk ◽

Katarzyna Jończyk-Potoczna ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Lymphoblastic Leukemia ◽

Childhood Acute Lymphoblastic Leukemia ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Long Term Survivors

Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P

Leukemia & Lymphoma ◽

10.1080/10428190600942769 ◽

2006 ◽

Vol 47 (12) ◽

pp. 2488-2504 ◽

Cited By ~ 35

Author(s):

Paul C. Nathan ◽

Trish Whitcomb ◽

Pamela L. Wolters ◽

Seth M. Steinberg ◽

Frank M. Balis ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Lymphoblastic Leukemia ◽

Preventive Therapy ◽

High Dose ◽

High Dose Methotrexate ◽

Cancer Group ◽

Dose Methotrexate ◽

Very High

ABCL-241: Comparing Efficacy of Intrathecal Chemotherapy versus High-Dose Methotrexate for Central Nervous System Prophylaxis in High-Grade B-Cell Lymphomas

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01875-9 ◽

2021 ◽

Vol 21 ◽

pp. S384

Author(s):

Nicole Ianniello ◽

Jose Sandoval-Sus

Keyword(s):

Central Nervous System ◽

Nervous System ◽

B Cell ◽

Intrathecal Chemotherapy ◽

High Dose ◽

High Grade ◽

High Dose Methotrexate ◽

B Cell Lymphomas ◽

Dose Methotrexate ◽

Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-019-04007-w ◽

2019 ◽

Vol 85 (1) ◽

pp. 133-140 ◽

Cited By ~ 1

Author(s):

Melissa J. Garwood ◽

Eliza A. Hawkes ◽

Leonid Churilov ◽

Geoffrey Chong

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Large B Cell Lymphoma ◽

Dose Methotrexate ◽

Central Nervous System Prophylaxis ◽

Large B Cell

Poster: ABCL-241: Comparing Efficacy of Intrathecal Chemotherapy versus High-Dose Methotrexate for Central Nervous System Prophylaxis in High-Grade B-Cell Lymphomas

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01515-9 ◽

2021 ◽

Vol 21 ◽

pp. S241

Author(s):

Nicole Ianniello ◽

Jose Sandoval-Sus

Keyword(s):

Central Nervous System ◽

Nervous System ◽

B Cell ◽

Intrathecal Chemotherapy ◽

High Dose ◽

High Grade ◽

High Dose Methotrexate ◽

B Cell Lymphomas ◽

Dose Methotrexate ◽

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion - Acute Leukemias IV ◽

Central Nervous System Prophylaxis with High Dose Methotrexate. A Pharmacokinetic and Clinical Study: Results of Protocol FRALLE 89

10.1007/978-3-642-78350-0_55 ◽

1994 ◽

pp. 314-316

Author(s):

G. Schaison ◽

M. F. Auclerc ◽

I. Madelaine ◽

A. Baruchel ◽

T. Leblanc ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Clinical Study ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Study Results ◽

PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL), RETROSPECTIVE ANALYSIS OF COMBINED CHEMO-RADIATION USING HIGH DOSE METHOTREXATE, EXPERIENCE FROM A SINGLE INSTITUTE

Research in Oncology ◽

10.21608/resoncol.2009.404 ◽

2009 ◽

Vol 5 (Issue 1-2) ◽

pp. 39-45

Author(s):

Mahmoud Abdelsalam

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Retrospective Analysis ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate

Management of Patients With Primary Central Nervous System Lymphoma Treated With High-Dose Methotrexate

Clinical Journal of Oncology Nursing ◽

10.1188/09.cjon.177-180 ◽

2009 ◽

Vol 13 (2) ◽

pp. 177-180 ◽

Cited By ~ 1

Author(s):

Elizabeth Warnick ◽

Danielle Auger

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate

Prevention of high-dose-methotrexate neurotoxicity by adequate folinic acid rescue is possible even after central nervous system irradiation

Medical Hypotheses ◽

10.1016/j.mehy.2006.04.074 ◽

2007 ◽

Vol 68 (5) ◽

pp. 1147-1153 ◽

Cited By ~ 16

Author(s):

Ian J. Cohen

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Folinic Acid ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Folinic Acid Rescue

High-Dose Methotrexate in Acute Lymphoblastic Leukemia: Where Is the Evidence for Its Continued Use?

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.25.5.748.63584 ◽

2005 ◽

Vol 25 (5) ◽

pp. 748-755 ◽

Cited By ~ 26

Author(s):

Elpis Mantadakis ◽

Peter D. Cole ◽

Barton A. Kamen

Keyword(s):

Lymphoblastic Leukemia ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Continued Use